Skip to main content
Clinical Trials/JPRN-jRCT1080220091
JPRN-jRCT1080220091
Unknown
Phase 4

A comparison of incidences of vertebral fracture in Japanese patients with osteoporosis treated with Etidronate and alfacalcidol; a randomized, double-blind study

Dainippon Sumitomo Pharma Co., Ltd.0 sitesSeptember 12, 2005

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Primary osteoporosis
Sponsor
Dainippon Sumitomo Pharma Co., Ltd.
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2005
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-Primary osteoporosis
  • \-Patient who had none or one to four vertebral (T4\-L5\) fracture(s)
  • \-Menopausal or postmenopausal woman or man aged 50 to less than 77
  • \-Patients who can walk (hospitalization/outpatient)
  • \-Secondary osteoporosis
  • \-Other diseases with reduced bone mass except secondary osteoporosis
  • \-Radiographic finding that might affect the vertebral intensity

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials